.png "Pfizer Beats Novo Nordisk in $10 Billion Metsera Deal")
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
The transition from volume-led growth to value- and innovation-led expansion is currently the defining trend of the Indian pharmaceutical business
Lupin has unveiled an ambitious tactical plan aimed at accelerating its growth through a strong product pipeline, widened market reach, and improved financial health. The company's latest update emphasizes a tightly managed approach
The Indian Pharmacopoeia Commission (IPC) intends to work on monographs and quality standards of three important TB drugs, such as delamanid, pretomanid and a fixed-dose combination (FDC) of rifapentine and isoniazid...
Positive results from the pivotal LIBERTY-AFRS-AIMS Phase 3 trial reveal that Dupixent considerably enhanced symptoms in adults and children aged six years and older with allergic fungal rhinosinusitis (AFRS). The investigational treatment met...
Biocon Ltd. informed that its Active Pharmaceutical Ingredient (API) manufacturing facility in Visakhapatnam, Andhra Pradesh
Torrent Pharmaceuticals got the green light from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to produce and sell Prucalopride Oral Solution (0.2 mg/mL).
.png "Mounjaro Becomes India's Top-Selling Drug at INR100 Crore")
Eli Lilly’s anti-obesity drug Mounjaro has become India’s highest-selling pharmaceutical by value in October, with sales touching ?100 crore ($11.38 million). The surge reflects the growing demand for anti-obesity medications in a country...
Zydus Lifesciences receives tentative USFDA approval for Olaparib Tablets (100mg, 150mg) used in treating BRCA-related ovarian, breast, pancreatic, and prostate cancers.
Alembic Pharmaceuticals Limited (Alembic), a pharmaceutical company engaged in vertically integrated research and development, has announced that it has obtained final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")